Akdamar Erol R 4
4 · HCA Healthcare, Inc. · Filed Nov 15, 2023
Insider Transaction Report
Form 4
Akdamar Erol R
Group President
Transactions
- Exercise/Conversion
Common Stock
2023-11-13$47.97/sh+26,825$1,286,795→ 26,825 total - Tax Payment
Common Stock
2023-11-13$229.99/sh−13,951$3,208,590→ 12,874 total - Exercise/Conversion
Stock Appreciation Right
2023-11-13−14,500→ 0 totalExercise: $47.97Exp: 2024-02-05→ Common Stock (14,500 underlying) - Exercise/Conversion
Stock Appreciation Right
2023-11-13−12,325→ 0 totalExercise: $47.97Exp: 2024-02-05→ Common Stock (12,325 underlying)
Holdings
- 42,484(indirect: By Trust)
Common Stock
- 60,000(indirect: By LLC)
Common Stock
Footnotes (2)
- [F1]The stock appreciation rights vested in four equal annual installments beginning on February 5, 2015.
- [F2]The stock appreciation rights vested at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the achievement of certain annual EBITDA performance targets.